Safety info for opioids found lacking

April 16, 2018

(HealthDay)—Information about safe storage and disposal of opioid painkillers on the drugs' package inserts is inconsistent, and even missing from some products, researchers report.

Incorrect or disposal of unused opioid painkillers is common and a major source of illegal opioid medication use, the new study found.

The researchers examined 98 inserts for six commonly prescribed and misused types of opioid pain relievers: Vicodin (hydrocodone); Exalgo (hydromorphone); Ultram (tramadol); fentanyl; morphine; and Oxycontin (oxycodone).

Collectively, the package inserts had one safe-storage message and three different types of safe-disposal messages. About two-thirds of the 35 package inserts with the safe-storage message and 70 to 80 percent of package inserts with a safe-disposal message were for oxycodone or morphine products.

None of the inserts for tramadol products had storage or disposal messages. And only one of the 33 package inserts for hydrocodone products had a storage or disposal message, according to lead study author Mitchell Doucette and colleagues at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.

The report was published April 16 in the Annals of Internal Medicine.

The findings show that lawmakers should consider requiring safe storage and disposal information on package inserts for all painkillers, the researchers said in a journal news release.

Explore further: DEA puts quota on production of opioid painkillers

More information: The U.S. National Institute on Drug Abuse has more about opioid medications.

Related Stories

DEA puts quota on production of opioid painkillers

October 6, 2016
(HealthDay)—The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of powerful prescription opioid painkillers.

Let's talk about Rx use—what is an opioid?

March 9, 2018
There are many reasons someone may take a prescription medication. We know these prescriptions are only safe when taken as directed by a medical professional for a specific health purpose, but for those who still choose to ...

What you can do to help fight the opioid epidemic

September 13, 2017
(HealthDay)—Proper disposal of prescription painkillers and use of safe alternatives to manage pain could help combat America's opioid abuse epidemic, doctors say.

Package inserts overstate diagnostic TB tests' accuracy

July 17, 2012
Clinicians and laboratory professionals often rely on manufacturers' package inserts to assess the accuracy of diagnostic medical tests. However, package inserts frequently greatly overstate such tests' accuracy, according ...

Study, research letter examine aspects of opioid prescribing, sharing

June 13, 2016
Pain-relieving prescription opioids are the subject of a new original investigation and research letter published online by JAMA Internal Medicine.

Addressing the double standard

October 9, 2017
A new editorial by JoAnn Manson, MD, DrPH in JAMA Internal Medicine highlights the need for physicians and pharmacists to educate women about the important distinctions between these hormone therapies

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.